Download GP Faxout

Downloads

• March 2010 | March 2010 flyers

PROJECT OFFICER INDIGENOUS HEALTH

Central Sydney GP Network (CSGPN)

CSGPN, based at Ashfield, is a progressive membership organisation providing support, resources and training to GPs and their staff in over 350 practices in Sydney’s inner west and Canterbury LGA.

We are seeking a full-time Project Officer working under the Closing the Gap – Improving Indigenous Access to Mainstream Primary Care Program. The role of the position will be to contribute to closing the gap in life expectancy by improving access to culturally sensitive primary care services for Indigenous Australians.

An attractive remuneration package will be negotiated with the successful applicant. For more information contact Peter Wood on 9799 0933 or pwood@csgpn.com.au. 

Applications close 5pm Friday 26 March 2010.

Australia’s Clinical Practice Guidelines Portal has been developed to help Australian clinicians and policy-makers access high quality, evidence-based clinical practice guidelines via a single entry point.

You will find links to clinical practice guidelines developed for use in Australian health care settings. Each guideline on this portal has been assessed according to rigorous selection criteria to help you find the type of guideline you are looking for.

The site provides direct links to guidelines or to guideline developer websites. The majority of guidelines linked to are free, however in a few instances payment is required.

http://www.clinicalguidelines.gov.au/

ME/CFS can lead to isolation and loneliness. With this in mind, an Inner West support group is beginning in 2010 for sufferers of Myalgic Encephalomyelitis (“ME”)/Chronic Fatigue Syndrome (“CFS”).

If you would like to meet with others with this condition in a social setting, please contact Katherine on 0415 702 891. Carers also welcome.

Meeting Dates

The new Inner West Support Group at Marrickville Council will meet on Saturdays, every six weeks starting in February 2010.

The dates for 2010 are:

Saturday 6 February
Saturday 20 March
Saturday 1 May
Saturday 3 July
Saturday 21 August
Saturday 2 October
Saturday 20 November

Information

For more information contact Katherine on 0415 702 891 or email: (JavaScript must be enabled to view this email address) or visit the MS/CFS Society of NSW website:

http://www.me-cfs.org.au

Download Practice Staff Bulletin

Download Central Express Bulletin

Download Practice Staff Bulletin

Download Central Express Bulletin

Advice to GPs on new Antenatal Shared Care (ANSC) advice.

Download Practice Staff Bulletin

BreastScreen NSW, Sydney South West has scheduled the following mobile van locations in the first six months of 2010.

BALMAIN
On the corner of Darling and Ford Streets, Balmain
8 March - 9 April

MARRICKVILLE
In Smidmore Street, outside Marrickville Metro Shopping Centre
8 March - 30 April

REDFERN
Outside 150 Pitt Street, Redfern
12 April - 23 April

CAMPSIE
Anzac Mall, Beamish Street, Campsie
28 April - 10 September

BreastScreen NSW provides a quality, free screening mammography service that especially targets women aged 50 to 69 years, as these women are in the group that will benefit the most from screening. All women over 40 years are eligible to access the Service.

BreastScreen Sydney South West also operates the permanent screening centres located at Bankstown, Bowral, RPAH Camperdown, Croydon and Liverpool.

For any additional information or to order BreastScreen resources including GP Referral Pads please contact the Health Promotion staff:
Balmain and Redfern Diane Mcleod on 9515 8749 or diane.mcleod@sswahs.nsw.gov.au
Marrickville and Campsie Tanya Vojsk on 9515 8748 or at tanya.vojsk@sswahs.nsw.gov.au

The support of general Practitioners in referring eligible women to BreastScreen remains of critical importance, thank you for your ongoing support.

Downloads

• February 2010 | February 2010 flyers

Download Central Express

ABC News report.

Alternate Browsers

Download alternative browsers for improved security and faster loading times.
Firefox Mac and PC
Opera Mac and PC
Wyzo Mac and PC

Download Practice Staff Bulletin

Download Central Express

To be able to book to deliver at RPA Women and Babies the patient must live in the suburbs covered by the RPA Antenatal Clinic available on the websites detailed below.

Some pateients requiring complex or specialised care who may live in Suburbs not covered by RPA Antenatal Clinic may be referred to RPA by their doctor. A letter of request is to be sent to the Director of Obstetrics and Gynaecology at RPA Women and Babies.

First antenatal visit

Women sometimes have difficulty accessing the Appointment Reception by telephone 9515 7101 as this is a very busy line.

For a patient to make her first Antenatal Visit appointment at RPA Women and Babies, she is required to please book either on-line or by fax:

On-line: www.rpawomenandbabies.com.au

• select ‘Information for Pregnant Women’; select ‘Public Patient Bookings’;
• fill in the ‘First Antenatal Appointment Form’ on-line and click ‘Submit’

This is a new website address to facilitate better access.
   
  or

fax to 9515 3454 with the same on-line form.

The First Antenatal Visit booking form is also available on the CSGPN website www.csgpn.com.au go the Antenatal Section on the home page and click on continue, screen down the page and after program clinical requirements are the links, with the RPA link, then click on departments and then Women & Babies.

A copy of the form is accessible as well as Medical Director and Best Practice templates. 

RPA Women and Babies follow up

Hospital staff will contact the woman via mail with an appointment date.

Booking process

All antenatal patients also need to book their bed for delivery after 20 weeks gestation (usually soon after the obstetric review visit). The woman will need to take her yellow card and registration form to the RPA Medical Centre Suite 210, Level 2, corner Carillon Avenue and Missenden Road.

The Booking Office is open from 7.30am till 5.00pm Monday to Friday.

Dr Robert Ogle
Executive Director
RPA Women & Babies
22 December 2009

Booking process for RPA Women and Babies Antenatal Clinic word document.

Downloads

• December 2009 | December 2009 flyers

Developed by Sydney South West Area Mental Health Service, consumer medication brochure series on Antipsychotic Medications, Benzodiazepine, Bipolar, Clozapine and Depression is now available on our website as PDF’s for you to download.

Consumer Medication Brochure Series

• CMB Antipsychotic Medications
• CMB Benzodiazepine
• CMB Bipolar
• CMB Clozapine
• CMB Depression

For more information regarding our Mental Health project, please contact Karen Frost on 8752 4910.

Downloads

• Central Viewpoint November issue 2009 | November Flyers

This article shows how Memorial Hermann serves a metro area of more than five million people, providing everything from air ambulance services to a chemical dependency treatment centre.

Apple - iPhone in Health Care Business.

If you have any comments or suggestions on the use of technology in the Healthcare system in Australia, please use the contact form on our website to let us know your thoughts.

Downloads

• H1N1 Flu Clinic Vaccination Guide

Downloads

• October 2009 | October 2009 Flyers

Please see the following attachments and guidelines for the national H1N1 vaccine roll out.

Timelines

• The vaccine will start to be delivered to those who have pre-ordered from TUESDAY 22 SEPTEMBER. The PROGRAM WILL START ON WEDNESDAY 30 SEPTEMBER
• See press release from Minister Roxon and DoHA
• The product was approved by the TGA for people 10 years of age and older.

Multi Dose Vial Guidelines

You will find the PDF MDV Guidelines as endorsed by ATAGI. These will also be available via the NSW Health H1N1 Vaccination website shortly.

IMPORTANT NOTE

• CSL tested the MDV and found that using the blunt drawing up needles produced “coring” (bits of bung in the vaccine) and jeopardised the integrity of the vial
• Hence a blunt 19G needle can only be used in the mass clinic setting where all doses are being drawn up and administered
• Otherwise 23G needle should be used to draw up the vaccine for individual doses. The VacPacs contain a long 23G needle that could be used for this purpose
• Panvax® will be distributed in packs (of varying sizes) of either 5mL (10 dose) OR 10mL (18 dose) MDV’s.

Vaccine eligibility

The vaccine is available for anyone who wants it over the age of 10.

Patient information sheet

A patient information sheet will be distributed with the vaccine and be available via the NSW Health H1N1 Vaccination website.

Consent form

This is optional as the vaccine is now TGA approved. If you still wish to use one, here is the Consent form PDF version.

Maternity guidelines

Further information will be available via the NSW Health H1N1 Vaccination website in the near future.

Indemnity

Please find a statement from the AMA for its members about indemnity for the H1N1 vaccination program.

Standing order

There will be no standing order developed. Authorised nurse immunisers do not need a standing order as this vaccine is to be regarded as an influenza vaccine (ie covered off in the Authority) and once the vaccine is licensed a PI (Product Information) will be available and included in all vaccine deliveries.

Indigenous communications

AMSs will receive a tailored poster from DoHA. The vaccine will be heavily marketed through Koori Radio.

Adverse events reporting

In contrast to usual procedures, providers are to be encouraged to report any AEFI of Panvax® directly to ADRAC as soon as possible after the event either by:
–      Electronic reporting
–      Blue Form:
If assistance is required contact your local Public Health Unit (PHU). PHU’s will record serious AEFI information supplied to them onto NDD and undertake any follow up required.

PENS

It’s recommended to write the date of opening onto the MDV; however this cannot be done with “ordinary” pens. CSL has kindly provided AGPN “Panvax® vial friendly” pens. These will be distributed to you via CSGPN as soon as they are received.

Further information

Please contact the Immunisation project office on 8752 4902 for further information.

Downloads

• September 2009 | September 2009 Flyers

NSW CID has just launched fact sheets for people with intellectual disabilities in Easy English to help the patient better understand and communicate health concerns and in standard English for family and health professionals. They contain very useful information to support Intellectually Disabled people to live healthier lives.

Link

www.nswcid.org.au

For further information Lisa Maude on 8752 4902.

From Monday 17 August 2009, all maternity units in Sydney South West Area Health Service (SSWAHS) will be offering vaccination with dTpa (Boostrix) to all mothers during the postnatal stay in hospital.

The objective of this policy is to reduce the risk and incidence of pertussis in newborns. As you will see from the 2 attached documents, this has the support of NSW Health and NCIRS. A brochure outlining the role of this injection will be given to each mother.

As General Practitioners usually take on the overall responsibility for vaccination records for their patients, it would be helpful if you ensure that your pregnant women are aware of this initiative and the implications of the new program.

Also could you please check with your postnatal patients whether they have been given the vaccination and ensure that there is a record of the vaccination being given as well as answer any questions they may have.

Dr Andrew Child AM
Clinical Director, Women’s Health and Neonatology
12 August 2009

Ph:   9515 8416
Fax:  9565 1595
Executive Unit
RPA Women and Babies

• Pertussis fact sheet
• Pertussis vaccination flyer
• Pregnant women info dtpa

Downloads

• August 2009 | August 2009 Flyers

Personal Protection Equipment from CSGPN on Vimeo.

Downloads

• CSGPN Pandemic Preparedness Workshop presentation.

Information

If you require any information regarding the PPE kits or the above demonstration, please contact Beba Ostrugnaj Phone: 8752 4909.

Downloads

• GP update 9
• Oseltamivir suspension

Downloads

• July 2009 | July 2009 Flyers

Download

• TGA safety advice regarding GARDASIL HPV vaccine.

Current status

Human cases of a new form of influenza virus have been identified in the United States and Mexico. The virus is a type of influenza A virus that is usually seen in pigs (“swine influenza”).

No cases of swine influenza have been confirmed in New South Wales or Australia. 27.4.2009

The World Health Organisation has declared the swine influenza situation to be a public health event of international significance.

Pandemic alert levels have not been raised by the World Health Organisation or by the Australian Government.

This event is of concern because:
• Swine influenza is derived from an animal influenza virus, which means that humans are likely to have little or no immunity to the virus
• There has been rapid spread to multiple communities overseas
• Swine influenza is affecting unusual age groups (healthy, young adults)
• The swine influenza virus is thought to be sensitive to the latest antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza)

For the most up-to-date information on the number of overseas confirmed cases of swine influenza please see:
• The World Health Organisation website
• and the United States CDC website

New South Wales is performing enhanced surveillance for the new swine influenza virus, by encouraging testing of people presenting with influenza-like illness or pneumonia who have recently returned from affected areas in the United States and Mexico.

NSW Health is working very closely with State and Commonwealth Government agencies to investigate and respond to this situation.

What you can do?

Influenza is spread from person-to-person through coughing or sneezing of infected people. There are many things you can do to prevent getting and spreading influenza:
• Cover your mouth when you cough, and wash your hands regularly.
• Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the garbage bin after you use it.
• Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hands cleaners are also effective.
• Avoid touching your eyes, nose or mouth. Germs spread that way.
• Try to avoid close contact with sick people.
• Influenza is spread from person-to-person through coughing or sneezing. Stay away from people who are sick.
• If you get sick, stay home from work or school and limit contact with others to avoid infecting them.

For more information, see the swine flu fact sheet.

Advice for recently returned travellers

If you have returned from the United States or Mexico within the last 7 days, and are feeling unwell with any flu-like symptoms, such as cough, fever, headache, joint aches and pains, fatigue, nausea, vomiting or diarrhoea, please contact your local Public Health Unit, or go to your nearest hospital emergency department and tell them that you have recently returned from overseas and may have flu.

Advice for clinicians

Clinicians should consider the possibility of swine influenza A virus (H1N1) infection in patients who have:

a) an influenza-like illness (fever and cough and fatigue) and who have travelled to Mexico or United States of America within the past seven days

or

b) pneumonia and who have travelled to Mexico or United States of America within the past seven days.

If swine flu is suspected, please isolate the patient, notify your local Public Health Unit, safely obtain a viral nose and throat swab for swine influenza testing and send it immediately to ICPMR at Westmead Hospital, or SEALS at Prince of Wales Hospital.

Please see the advice to clinicians from the Chief Medical Officer.

Five teams of CSGPN representatives woke up in the wee hours of Sunday morning in preparation for the BRW triathlon series that months ago sounded like a good idea!
by Julia Thompson

We contemplated when and what foods should be eaten leading up to event, checked and doubled checked we had everything we needed and almost all of the CSPGN team decided they couldn’t face the task without their morning coffee.

After arriving before 6.30am to have our bikes checked in, the teams settled in with the other 4500 people waiting for our allocated time slots at 9.25 (female) and 10.10 am (men). Letting the waves of nerves, excitement (mainly for it to be over!) and apprehension to (including fear of sharks!) roll over us.

Miserable weather lead up to the event but a beautiful morning was produced just in time for our 400 m swim, 8km ride and 4km run.

All teams completed the race with some fierce competition between the male contenders. John Mulley our triathlon organiser, ran a great race completing the course in just over 35 minutes, followed closely by Philip Vita and our chief Dr Michael Moore who beat his time last year by 30 odd seconds. And in the process scraped in just in front of his wife Dr Candice Newberry, the fastest placed women for (40 minutes) CSGPN.

A big congratulations to all those who competed the race, including 11 first timers and to Sue Moxon who managed to complete the event with a migraine. It was a great day for all who came and next year we hope for even more team members and faster times for those returning.

The results

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

Position	Time	Firstname	Surname
630	0:35:37	John	MULLEY
1693	0:39:24	Philip	VITA
1937	0:40:16	Michael	MOORE
2068	0:40:45	Candace	NEWBERRY
2350	0:41:50	Charlotte	HESPE
2406	0:42:03	Kerstin	WALTHER
2606	0:43:03	Julia	THOMPSON
2708	0:43:31	Kristina	FLEGO
2709	0:43:31	Hester	WILSON
2902	0:44:26	Marcela	COX
3329	0:47:35	Melissa	FRANKLIN
3430	0:48:25	Fan	YANG
3572	0:50:04	Alison	MUDIE
3575	0:50:05	Lara	LEIBBRANDT
4002	1:11:48	Sue	MOXON

CSGPN will be arranging more team events for its membership to be involved in at all levels. If you would like to participate in any events, regardless of your fitness level, please contact John Mulley and we’ll ad you to our list and advise on upcoming challenges.

Photos

 

New Australian Alcohol Guidelines - the National Health and Medical Research Council’s (NHMRC) Australian Guidelines to Reduce Health Risks from Drinking Alcohol were released on 6 March 2009.
The key changes include the following revised guidelines:

Guideline 1

For healthy men and women, drinking no more than two standard drinks on any day reduces the lifetime risk of harm from alcohol-related disease or injury.

Guideline 2

For healthy men and women, drinking no more than four standard drinks on a single occasion reduces the risk of alcohol related injury arising from that occasion.

Guideline 3

3A Parents and carers should be advised that children under 15 years of age are at the greatest risk of harm from drinking and that for this age group, not drinking alcohol is especially important.
3B For young people aged 15–17 years the safest option is to delay the initiation of drinking for as long as possible.

Guideline 4

4A For women who are pregnant or planning a pregnancy, not drinking is the safest option. 
4B For women who are breastfeeding, not drinking is the safest option.

Alcohol has a complex role in Australian society. Most Australians drink alcohol, generally for enjoyment, relaxation and sociability, and do so at levels that cause few adverse effects. However, a substantial proportion of people drink at levels that increase their risk of alcohol-related harm. For some, alcohol is a cause of significant ill health and hardship. In many countries, including Australia, alcohol is responsible for a considerable burden of death, disease and injury. Alcohol-related harm to health is not limited to drinkers but also affects families, bystanders and the broader community.

NHMRC intends Australian Guidelines to Reduce Health Risks from Drinking Alcohol to establish the evidence base for future policies and community materials on reducing the health risks that arise from drinking alcohol. It is about helping you to help your patients reduce the risks to their health from drinking alcohol.

Of course, how much your patients drink is their choice. But the NHMRC hope these guidelines will help you to help your patients make an informed choice and also help health agencies guide the community in reducing health risks. Click on the following links to view and download the indicated resources:

• Download the Australian Guidelines to Reduce Health Risks from Drinking Alcohol
• Summary of the Guidelines
• Alcohol FAQ
• The Australian standard drink

Alternatively you can view and download the new guidelines, including a summary, FAQs and standard drink guide by clicking on the following link at:
http://www.nhmrc.gov.au/your_health/healthy/alcohol/index.htm
Information and resources relating to the new guidelines will soon be available on www.alcohol.gov.au from late April 2009.

For more information contact:

Project Officer: Karen Frost
Phone: 8752 4910

In coming years more than 21,000 older women with osteoporosis are expected to benefit from the addition of zoledronic acid (Aclasta®) to the PBS. The once-a-year injection will be available for women over 70 years with a bone mineral density score of -3.0 or less.

This is the third treatment option available under the PBS for osteoporosis and recognises the growing number of people, especially older women, with the condition. According to Osteoporosis Australia, someone is admitted to an Australian hospital with an osteoporotic fracture every eight minutes.

The listing of zoledronic acid will add about $20 million to the PBS over the next five years.

Children aged 1-10 years with tyrosinemia will benefit from the listing of amino acid formula with vitamins and minerals without phenylalanine (PKU Anamix Junior LQ® and Lophlex LQ 10®). Tyrosinemia is an inherited disorder of amino acid metabolism that causes liver disease and is treated with a diet low in the amino acid tyrosine.

There are no expected cost implications for the PBS as this medication will be a substitute for other PBS medications.

Restless legs syndrome (RLS) is a neurological disorder characterised by unpleasant sensations in the legs and an uncontrollable urge to move when at rest in an effort to relieve these feelings.

The listing of pramipexole hydrochloride (Sifrol®) on the PBS has been extended to include treatment of severe primary RLS, and is expected to benefit more than 25,000 patients over the next five years. This will add about $18 million to the PBS over the next five years.

A variety of additional treatments for existing medications will now be subsidised through the PBS.

An oral solution of escitalopram oxalate (Lexapro®) will provide an additional treatment method for people with moderate to severe generalised anxiety disorder and social anxiety disorder. There are no expected cost implications for the PBS as this will substitute existing PBS medications.

A new formulation for desmopressin acetate (Minirin Melt®) as a wafer put under the tongue will provide an additional treatment method for primary nocturnal enuresis (bed-wetting). There are no expected cost implications for the PBS as this will substitute other medications.

A new solution concentrate for an in vitro infusion of gemcitabine hydrochloride (Gemcitabine Ebewe®) has been added to the PBS to treat a variety of cancer conditions, including breast cancer, epithelial ovarian cancer, non-small cell lung cancer and bladder cancer. There are no expected cost implications for the PBS as this medication will substitute for different forms of the same strengths of the same medication.

Two additional strengths of oxycodone hydrochloride (OxyContin®) tablets will be added to the PBS for the management of moderate to severe chronic pain that is unresponsive to non-narcotic analgesia. This listing will provide patients with increased convenience. There are no expected cost implications for the PBS as this will substitute for other forms of this PBS medication.

The listing of ziprasidone hydrochloride (Zeldox®) has been extended to include monotherapy, for up to six months, of an episode of acute mania or mixed episodes associated with bipolar I disorder. There are no expected cost implications for the PBS as this will substitute for other PBS medications.

Changes to the Highly Specialised Drugs Program from 1 April 2009 will broaden the subsidised use of filgrastim (Neupogen®) and pegfilgrastim (Neulasta®) to assist some people with chronic lymphocytic leukaemia.

Chronic lymphocytic leukaemia is the most common form of leukaemia in Western countries and occurs primarily in older people, with men twice as likely to develop the condition.

The changes will cover patients being treated with fludarabine and cyclophosphamide who have secondary prophylaxis of neutropenia or prolonged severe neutropenia. This will assist more than 900 patients over the next five years.

Neutropenia is a condition of an abnormally low number of a particular type of white blood cell neutrophil. Treatments such as chemotherapy and radiation therapy can cause neutropenia.

The extension of filgrastim and pegfilgrastim of will add about $15.4 million to the PBS over the next five years.

People who have had a stroke and have moderate to severe spasticity of the upper limb will benefit from the extension of botulinum toxin type A (Botox®). According to the National Stroke Foundation, Australians will suffer around 60,000 new and recurrent strokes this year alone.

This treatment will be available as second line therapy when standard management has failed, or as an adjunct to physical therapy. There are no expected cost implications for the PBS as this will replace as existing therapy.

Further information

RADAR (Rational Assessment of Drugs and Research) provides information on new drugs.

Project officers:
Beba Ostrugnaj Phone: 8752 4909
Vijay Ramanathan Phone: 8752 4915
Julie McLean-Murray Phone: 8752 4905

Mood disorders in General Practice - as simple as DSM, SSRI & CBT?

The webcast
In the past decade mental health, and depression in particular, has received a great deal of attention both in the general and medical media. Awareness of depression has markedly increased, attempts have been made to reduce its stigma, and a lot of effort has gone into educating GPs.

No-one would argue that this has not been a positive development. However it has lead on occasions to an oversimplification, where all bad moods are depression, and depression always responds to evidence based treatment with CBT & an SSRI.
Clinical reality in general practice is rather different. We see a wide range of low moods, only some of which are unipolar depression. Many belong to other diagnoses, and many, despite being very significant, struggle to fit neatly any single DSM category. General practice is messy and our patients rarely conform to the neat case studies of typical education modules. And treatments may be evidence based, but the patients to whom we offer them are rarely the same as those carefully selected folk from whom the evidence was gathered.
This talk tries to step back a little and look first at normal mood and its adaptive function, and then go on to take an honest look at the diverse range of mood presentations in GP. In no sense didactic, it is one particular GP’s reflections on how he approaches the manifold uncertainties around treating mood dysfunction. It touches on the difference between the cross sectional, phenomenologically driven approach of some specialist practitioners and the more longitudinal, formulation based approach often found in general practice. It touches on lifestyle, ‘second line’ pharmacological treatments and when to move beyond CBT & explore the meaning of depressive symptoms.

The presenter
Dr Simon Cowap MBBS (Hons) FRACGP is a GP with a long interest in mental health. He is currently practicing at the Brain & Mind Research Institute (BMRI), Camperdown, headspace (youth mental health initiative) in Campbelltown, and in private mental health focused practice in Glebe. He is a level II mental health accredited practitioner, and has both attended and helped design and deliver a number of mental health education initiatives for general practitioners. He has written on general and mental health issues for publications including the Australian Family Physician, Medical Observer, the Australian newspaper and a variety of internet sites. He is currently assisting in the development of the BMRI’s post graduate education programme for GPs intended to commence in 2010. He is interested in the collaborative care of mental health patients and the unique perspective GPs bring to the mental health team.

Accessing and participating in the broadcast
The live broadcast will be a presentation to a small studio audience. The talk will last approximately 30 to 40 mins with 20 minutes for questions. You will be able to watch the live webcast at home on your computer, and the program will allow you to type in questions which the speaker can address during the question time. Access is free to ACPM members and members of the Central Sydney GP Network - co-sponsors of this webcast.

Instructions for viewing
This event is free to financial members of CSGPN, details can be viewed by logging in to the Members section of this website or contact us for further details.

If you are not able to view the live webcast you will be able to access it a few weeks later on the web site by going through the above steps.

For further information please contact: 
Dr Howard Gwynne
email: howard@aya.yale.edu
ph: 0402 827 156

Three Key points for GPs

1. The pertussis epidemic continues in NSW. Babies who are too young to be fully vaccinated are most at risk
2. For a limited time, dTpa vaccine will be provided free for all new parents, grandparents and any other adults who regularly care for infants
3. DTPa (Infanrix-hexa) can be given to babies from 6 weeks of age

Timely immunisation of infants is important because unvaccinated infants are at highest risk of infection and are also at high risk of complications. Because pertussis immunity wanes over time, many older children and adults are susceptible to infection and can be the source of new infections in infants.

For a limited time, FREE dTpa vaccine will be available for all new parents, grandparents and any other adults who will regularly care for infants less than 12 months of age.

GPs should advise all new parents to:
• Vaccinate their baby on time.
• Keep their baby away from anyone with a cough.

For new parents, GPs should:
• Check the immunisation status of new parents and other children and provide catch-up vaccination.
• Offer FREE dTpa vaccine to new parents, grandparents and any other adults who regularly care for infants.
• Consider vaccinating infants at 6 weeks if the opportunity arises. Infanrix-hexa, Prevenar and Rotarix are all licensed for use in infants from 6 weeks of age. The next scheduled vaccines should be given at 4 and 6 months of age.

Who is eligible for the FREE dTpa vaccine?
• Couples who are planning a pregnancy (both parents).
• New parents (mothers should be vaccinated as soon as possible after childbirth).
• Grandparents and other adults who will regularly care for the infant.

Ordering FREE dTpa vaccine for adults
Fax order form to the NSW Vaccine Centre on 1800 041 528. Download:
Pertussis outbreak response order form.
Additional guidelines for ordering free dTpa vaccine

For further information, GPs can call the Public Health Unit at Camperdown on 9515 9420.

From January 2009, the Medicare audit scheme will increase from 0.7% to 4% (500 to 2500 audits per year) of all providers with includes GPs, allied health professionals and specialists. The audits are carried out on claims that consistently produce anomalies in claiming procedures. Medicare acknowledged that the majority of non-compliant audits are not the acts of lawless scoundrels but more an administrative glitch.

For more information about MBS audits, visit the Medicare website and look for the fact sheet titled Increased MBS Compliance Audits Information Sheet or call Lisa Maude on 8752 4902.

The Melancholia Study Team is pictured (from left to right): David Gilfillan, Tania Perich, Iain MacMillan, Bianca Blanch, Gordon Parker, Vijaya Manicavasagar, Dusan Hadzi-Pavlovic, Alex Apler.

The Black Dog Institute is offering immediate free specialist psychiatric and psychological consultations for up to 300 people experiencing melancholic depression as an inducement to participate in a 12-week trial. The reality is that currently people are waiting up to three to six months when they are referred to see a mood disorder specialist, according to the Black Dog Institute. The “queue jumping” trial announced 17 February 2009, will allow people to receive free treatment and make a valuable contribution to a study that is designed to measure best treatments for melancholic depression. Professor Parker, Executive Director of the Black Dog Institute, has also given an undertaking that if the participants have not improved following the 12-week trial, the Institute will offer ongoing free management for their condition.

Black Dog Institute
Hospital Road
Prince of Wales Hospital
Randwick NSW 2031

Business Hours: MON-FRI 9am-5pm
Reception/Deliveries/General Information: 9382 4530
Community/Consumer Enquiries: 9382 4523
Clinics: 9382 2991
Fax: 9382 8208
Email: blackdog@unsw.edu.au

The growing role of Practice Nurses - focusing on the 4 year old health check

Practice nurses will play an increasing role in the delivery of primary healthcare, but did you know since 2004 over 14 million Medicare item numbers specific to practice nurses have been claimed? One of the latest item numbers is the 4 year old health check.

APNA invited practice nurses to attend this special event held at Shepherd’s Bay Community Centre in Meadowbank, to raise the awareness and understanding of the role of practice nurses in the delivery of primary healthcare.

Speakers included:

• The Hon Maxine McKew, MP, Parliamentary Secretary for Early Childhood Education and Child Care
• Mayor of Ryde, Cr Vic Tagg
• Karen Booth- Practice Nurse Perspective
• APNA CEO and President
• GP Northside Representative

If you would like more information about the 4 year old health check, please contact Jo Wild on 8752 4919 or Lisa Maude on 8752 4902.

Visit the DoHA: Healthy Kids for questions about the Government’s Healthy Kids Check or visit the NSW Healthy Kids website for consumer information.

Central Sydney GPs will shortly be able to refer eligible patients for free psychological therapy to our selected Access to Allied Psychological Services (ATAPS) providers with expertise in PND
Recent studies show that 1 in 7 women in Australia experience postnatal depression. The aims are to provide better care, support and treatment for expectant mothers, new mothers and their families.

Our current ATAPS and Antenatal Shared Care projects will be combining forces to run this project in our area. Key activities of this project include the following:

• establishing linkages and relationships with local child and maternal health services and primary mental health care services to ensure that women experiencing perinatal depression and their families have the necessary resources available to them;
• as appropriate, promoting the use of other pathways to care for women experiencing perinatal depression and their families;
• ensuring that women experiencing perinatal depression and their families are able to receive treatment under ATAPS; and
• promoting and disseminating materials and resources to GPs and allied health professionals to support professional practice in respect of perinatal depression treatment and support;

Discussions are being held with the key SSWAHS service providers as well as Karitane and Tresillian on how best to ensure this program meets the needs of the most at risk women.

Karen Frost (ATAPS) and Dianne Deschamps (ANSC) are interested in speaking to GPs who care for large numbers of women from Culturally and Linguistically Diverse Backgrounds to see how this initiative would assist the women you care for.

Do not hesitate to contact either Karen Frost on 8752 4910 or Dianne Deschamps on 8752 4923 for further information or advice regarding this program.

www.psychevisual.com
The psyche in health and illness is an innovative approach to adult learning in the fields of psychology, psychiatry and mental health care. Users will find papers and multimedia presentations easy to access and are given a wide range of material of value to professionals and to the interested public. The access to the content of this site is free to members of Central Sydney GP Network and the Australian College of Psychological Medicine, otherwise access is by subscription, on a pay per view or pay to download basis.

The site is a valuable aid for people in professional training and is highly informative for consumers of mental health services. The site has interactive capabilities so subscribers will have the possibility of occasions of direct interaction with speakers. Many of our speakers are leaders in the field and we provide information about all speakers and their publications which can be ordered via this site.

For further information, contact:
Project Officer: Karen Frost
Phone: 8752 4910

This clinic will run on Friday mornings in the Women’s Health Ambulatory Care area on level 5 and will be led by Dr Kirsten Black, a consultant gynaecologist and clinical academic. Access will only be by GP referral or referral from other RPAH specialty units. The clinic is for women with complex medical conditions requiring contraceptive advice and management and for women requiring intrauterine device insertion that is not able to be undertaken in the community setting. Gynaecology appointment forms, presently available on the SSWAHS website and used by GPs for faxing requests for appointments, will be updated to include this new clinic.

Previously Bali was considered rabies free; hence this presents a new risk to Australians visiting Bali.

The Indonesian media have also reported that several people with rabies-like clinical signs and symptoms have died after being bitten by dogs. There is at present no indication that the disease has spread to animals other than dogs. However any animal should be considered to pose a potential risk.

NSW Health recommends that all adults and children visiting Bali should avoid contact with wild and domestic animals, including dogs, cats and monkeys, even if the animal appears well.

“Anyone who is bitten or scratched by an animal in a rabies-affected area, including Bali should immediately wash the wound well with soap and water, apply an antiseptic such as povidone iodine to the wound and see a doctor as soon as possible,” Dr Andrew Marich, Acting Director of NSW Health’s Communicable Diseases Branch, said.

“A course of injections is sometimes needed to prevent rabies infection developing after a bite or scratch,” he said.

NSW Health advises that anyone who has been bitten or scratched by any animal in Bali since 1 August 2008 should see their general practitioner for advice. People bitten or scratched by an animal before this time are not thought to be at risk of rabies.

Rabies is transmitted when viruses in a rabid animal’s saliva get into nerve cells through a wound – usually following a bite or a scratch. While many rabid animals will be sick and may go on to die, some appear well.

Symptoms in humans may include headache, fever, feeling unwell, sensory changes around the site of the bite or scratch, excitability, an aversion to fresh air and water, weakness, delirium, convulsions, and coma.

If rabies infection has occurred, symptoms in humans normally begin within several weeks but sometimes the symptoms begin years after infection. Death usually follows several days after the onset of symptoms.

There is no treatment for rabies once the symptoms have started however treatment of infected people before they develop symptoms can be effective.

The Governor of Bali has temporarily banned the import or export of dogs, cats, monkeys and other animals declaring the island under official quarantine until further notice. Officials are also endeavouring to create a perimeter of vaccinated animals in the areas immediately surrounding those areas in which rabies has been confirmed, aiming to isolate and eventually eliminate the disease.

For a copy of the fact sheet on rabies go to NSW Health Fact Sheet.

NSW Mental Health Act 2007 involuntary schedule of a mental health patient form. Please click on the following links for Schedule 1 - medical certificate as to examination or observation of person:

• Medical Director template
• Best Practice template
• How to import templates from CSGPN website Handout : Medical Director or Best Practice

For further information please contact:
Project Officer: Karen Frost
Phone: 8752 4910

As of December 15 2008, CSGPN has officially moved to its new home. Located in Liverpool Road, close to Parramatta Road, the office is much larger and accomodates a new training facility on site.

Evidence from a range of different studies conducted in Australia, the United States, China, Japan, Finland and Germany indicates that regular moderate to vigorous exercise, in combination with dietary changes, can prevent or delay the onset of Type 2 diabetes.

More recently, landmark intervention studies in China (The China Da Qing Diabetes Prevention Study) the US (The Diabetes Prevention Program) and Finland (The Finnish Diabetes Prevention Program), have shown that sustainable lifestyle interventions in people at high risk of developing type 2 diabetes, led to significant reductions in the incidence of diabetes, by up to 58%.

About Lifestyle Modification Programs

A key component of the Commonwealth Government’s Prevention of Type 2 Diabetes Program, is the ability for a GP to refer eligible patients to accredited, subsidised Lifestyle Modification Program (LMPs) to prevent, or delay, the onset of Type 2 diabetes.

Patients who are at high risk of type 2 diabetes based on the AUSDRISK tool, can be referred to LMPs under an item 713 (Type 2 diabetes risk review), item 717 (45-49 year old health check) or item 710 (Indigenous adult 15-54 year old health check).

The divisions of general practice network will fund, and in some cases, provide LMPs.

These LMPs will typically be a series of group education and motivation sessions supporting lifestyle change.  LMPs need to ensure they meet the draft standards for lifestyle modification programs for people at risk of type 2 diabetes, and be awarded accreditation before they can start delivering services.  Any LMP that is not accredited, will not be eligible to deliver services, receive GP referrals or receive payment.  For more information on accreditation, visit the accreditation sub-page.

LMP’s will provide information on:

• the risks of diabetes and their relationship to lifestyle risk factors;
• the importance of regular diabetes screening;
• nutrition advice and education;
• physical activity advice;
• behavioural strategies to support the adoption and maintenance of healthy lifestyle changes;
• smoking cessation and alcohol reduction advice if required; and
• information about community resources to provide support in maintaining lifestyle change.

How long is a Lifestyle Modification Program?

Lifestyle Modification Programs must be structured in accordance with the draft national standards.  These standards require an LMP to run for a least 6 months, with an initial intensive phase of at least 4 months.

For further information on the required format of LMPs and core competencies for facilitators, refer to the draft standards.

The Consumers Health Forum of Australia (CHF) congratulates the Minister for Health and Ageing on her announcement that consumers and other stakeholders will now be able to comment on medicines being considered for listing on the Pharmaceutical Benefits Scheme (PBS). 

CHF has advocated for more transparency around the PBS listing process for several years. It provided input for this initiative to the Australian Department of Health and Ageing based on the
need to add the consumer experience to the evidence base.

‘The Pharmaceutical Benefits Advisory Committee (PBAC) makes final decisions about which medicines are listed on the PBS. It has a consumer representative, but this initiative allows more direct consumer input into the decision-making process,’ CHF Executive Director Helen Hopkins said.

‘The PBAC meeting agenda will be publicly available on its website six weeks before each meeting, stating which medicines are being considered. Consumers and others will have access to an online form for the following two weeks to comment on how consumers, their family and carers would benefit from PBS listing. Comments will be examined by the PBAC and the pharmaceutical company that applied for the PBS listing before the meeting.’

Ms Hopkins said this was a significant improvement in transparency around the PBAC process, and followed other consumer-driven improvements.

‘The release of public summary documents by the PBAC after decisions had been made has helped consumers understand the decision-making process and the reasons why medicines are approved or
rejected.  The inclusion of a consumer representative on the PBAC has led to robust debate about the availability of medicines and how to improve access to medicines,’ she said.

‘A CHF pilot project with the PBAC to test consumer impact statements has shown the value that consumer experiences can add to the decision making processes. The statements look at the impact
of specific conditions on people’s daily lives that can be taken into account by the PBAC when looking at medicines to treat those conditions.’

Outgoing CHF Chairperson Mitch Messer is the current consumer member on the PBAC. 
For further information contact:
Helen Hopkins, CHF Executive Director, on 0412 065 957

Sydney South West Area Health Service (SSWAHS) is currently working on a waterpipe tobacco awareness raising campaign targeted at the Arabic community. This has involved education and awareness raising on the relevant legislation and the harmful effects of waterpipe tobacco through media outlets such as radio and newspapers.

This rising popularity is linked to an incorrect belief that waterpipe tobacco smoking is less dangerous than cigarette smoking. It has also become popular because of the introduction of flavourings,
its wide availability, low cost, and marketing. These factors have made waterpipe tobacco smoking socially acceptable. It is used by both men and women, usually at social gatherings at home or at bars and cafes which offer waterpipe.

 

Advice from the Department of Health and Ageing regarding Melamine contamination of White Rabbit Creamy Candy that has been in the media. This alert is to notify medical practitioners that a brand of confectionary “White Rabbit Creamy Candy” has potentially been contaminated with a toxic chemical substance, Melamine.
It has not been confirmed that Candy contaminated with Melamine has been distributed to Australian consumers. This notice is being provided on a precautionary basis to assist with identifying cases of toxicity which might occur. Advice for GPs to download.

Dr Tony Hobbs, Chair of AGPN, today announced the appointment of Mr David Butt as the new CEO of the AGPN. Dr Hobbs said he and the Board “are pleased to be able to work with Mr Butt to take the divisions of general practice network forward”.
Mr Butt said: “I am delighted to be taking up this very important position at a time of potentially significant reform of the Australian health care system, including increased recognition of the crucial role of primary health care.  The divisions network is a vitally important part of our health system, central to the strengthening of primary care in Australia, and fundamental to achieving real improvements in our health system.”
Mr Butt, who will commence in the role on 13 October, is the former National CEO of Little Company of Mary Health Care (the Calvary group) where he oversaw the operation of major public and private hospitals as well as residential aged care and home care services spanning urban, regional and remote communities in six States and Territories. LCM Health Care is also Australia’s largest palliative care provider. 
Mr Butt was previously the Chief Executive of ACT Health and chaired the Australian Health Ministers Advisory Council (AHMAC) for two years.  He has also worked at an executive level in the Queensland health system, including as Executive Director Policy and Planning (where he oversaw development of the state’s first Aboriginal and Torres Strait Islander health policy) and Regional
Director, Peninsula and Torres Strait.
Dr Hobbs paid tribute to Ms Liesel Wett for her dedication and commitment in the role of acting CEO since June.
AGPN is the peak national body representing a dynamic network of 111 regional and eight state-based organisations driving innovation and quality improvement in general practice in partnership with their local communities and other stakeholders.  AGPN is the largest voice for general practice in Australia with over 95 per cent of Australia’s GPs members of their local division. The network delivers local health solutions through general practice. 
For further information or to organise a media interview, please call Jamie Snashall on 0407 438 746